US FDA accepts Santhera, ReveraGen’s vamorolone NDA to treat DMD

Vamorolone secured Orphan Drug status in the US and in Europe for DMD. Credit: Dr. Edwin P. Ewing, Jr. / commons.wikimedia.org.